invIOs GmbH
PrivateLast Round
Series A
Oct 15, 2024
Total Funding Raised
$8.94M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
invIOs GmbH is a biotechnology company that develops next-generation cancer immunotherapies using its proprietary EPiC cell therapy platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
invIOs GmbH Comparables
Compare invIOs GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HotSpot Therapeutics | 68% | |
| Adaptimmune Therapeutics | 68% | |
| Nurix Therapeutics, Inc. | 68% |
invIOs GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 15, 2024 |
invIOs GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ligand Pharmaceuticals | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 315% MoM.
- Jul 25, 2026
Monthly visitors increased 1667% MoM, from 36 to 636.
invIOs GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about invIOs GmbH's valuation, stock price, and market status.
Is invIOs GmbH a public or private company?
invIOs GmbH is a private company.
What is the current stock price of invIOs GmbH?
invIOs GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is invIOs GmbH worth (valuation)?
Valuation information for invIOs GmbH is not publicly available.
Can I buy invIOs GmbH stock?
invIOs GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was invIOs GmbH's last funding round?
invIOs GmbH's most recent funding round was Series A on October 15, 2024.
Who are the main investors in invIOs GmbH?
Key investors in invIOs GmbH include Ligand Pharmaceuticals.
Will invIOs GmbH IPO soon?
No public IPO plans have been announced for invIOs GmbH.
How can I track invIOs GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor invIOs GmbH's secondary market activity and sign up for updates.